World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
49
Citations
12049
World Ranking
17889
National Ranking
7321

J. Brooks Jackson publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where J. Brooks Jackson sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 156 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

J. Brooks Jackson D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where J. Brooks Jackson sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 49 D-Index — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

J. Brooks Jackson is affiliated with the University of Iowa Hospitals and Clinics in the United States. Their research contributions primarily focus on the field of Medicine, with a significant number of publications in Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health, Obstetrics and Gynecology, and Surgery.

The scientist has worked extensively on topics including COVID-19 Clinical Research Studies, Hepatitis B Virus Studies, SARS-CoV-2 and COVID-19 Research, Cervical Cancer and HPV Research, Pelvic floor disorders treatments, COVID-19 Impact on Reproduction, and Tuberculosis Research and Epidemiology.

The following are some of their recent papers along with the year of publication and venue:

  • Human Papillomavirus and Associated Cancers: A Review, 2024, Viruses
  • Prevalence of pelvic floor disorders in adult women being seen in a primary care setting and associated risk factors, 2022, Scientific Reports
  • Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays, 2020, The Journal of Applied Laboratory Medicine
  • COVID-19 convalescent plasma: phase 2, 2020, Transfusion
  • SARS-CoV-2 Infection during Pregnancy in a Rural Midwest All-delivery Cohort and Associated Maternal and Neonatal Outcomes, 2021, American Journal of Perinatology

J. Brooks Jackson frequently collaborates with several co-authors. These include Linder Wendt, Mary B. Rysavy, Kimberly A. Kenne, Anna E. Merrill, and JaNiese E. Jensen.

The scientist's work is often published in venues such as:

  • Journal of Medical - Clinical Research & Reviews
  • Microbiology & Infectious Diseases
  • Transfusion
  • American Journal of Perinatology
  • PLoS ONE

Best Publications

  • Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

    Laura A Guay;Philippa Musoke;Thomas Fleming;Danstan Bagenda

  • Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial

    J. Brooks Jackson;Philippa Musoke;Thomas Fleming;Thomas Fleming;Laura A. Guay

  • The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter

    David A. Katzenstein;Scott M. Hammer;Michael D. Hughes;Holly Gundacker

  • Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

    Susan H. Eshleman;Martin Mracna;Laura A. Guay;Martina Deseyve

  • Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection

    Craig W. Hendrix;Ann C. Collier;Michael Marcel Lederman;Dominique Schols

  • Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa

    Elliot Marseille;James G Kahn;Francis Mmiro;Laura Guay

  • Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials.

    Six Week Extended-Dose Nevirapine (Swen) Study Team;Abubaker Bedri;Berhanu Gudetta;Abdulhamid Isehak

  • Sensitive Drug-Resistance Assays Reveal Long-Term Persistence of HIV-1 Variants with the K103N Nevirapine (NVP) Resistance Mutation in Some Women and Infants after the Administration of Single-Dose NVP: HIVNET 012

    Tamara Flys;Dwight V. Nissley;Cassidy W. Claasen;Dana Jones

  • A phase I / II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).

    Philippa Musoke;Laura A. Guay;Danstan Bagenda;Mark Mirochnick

  • Nevirapine (NVP) Resistance in Women with HIV-1 Subtype C, Compared with Subtypes A and D, after the Administration of Single-Dose NVP

    Susan H. Eshleman;Donald R. Hoover;Shu Chen;Sarah E. Hudelson

  • Coreceptor Tropism in Human Immunodeficiency Virus Type 1 Subtype D: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations

    Wei Huang;Susan H. Eshleman;Jonathan Toma;Signe Fransen

  • Multicenter Evaluation of Use of Dried Blood and Plasma Spot Specimens in Quantitative Assays for Human Immunodeficiency Virus RNA: Measurement, Precision, and RNA Stability

    Don Brambilla;Cheryl Jennings;Grace Aldrovandi;James Bremer

  • Antenatal Vitamin A Supplementation Increases Birth Weight and Decreases Anemia among Infants Born to Human Immunodeficiency Virus-Infected Women in Malawi

    Newton Kumwenda;Paolo G. Miotti;Taha E. Taha;Robin Broadhead

  • Diagnostic utility of telomere length testing in a hospital-based setting

    Jonathan K. Alder;Vidya Sagar Hanumanthu;Margaret A. Strong;Amy E. DeZern

  • Absence of HIV infection in blood donors with indeterminate western blot tests for antibody to HIV-1.

    J. Brooks Jackson;Kristine L. Macdonald;Jane Cadwell;Carolyn Sullivan

  • Multicenter Evaluation Of Quantification Methods For Plasma Human Immunodeficiency Virus Type 1 Rna

    Hsiang Ju Lin;Lawrence E. Myers;Belinda Yen-Lieberman;F. Blaine Hollinger

  • Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012).

    Susan H. Eshleman;Laura A. Guay;Anthony Mwatha;Elizabeth R. Brown

  • Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns.

    Susan H. Eshleman;Donald R. Hoover;Shu Chen;Sarah E. Hudelson

  • Impact of Human Immunodeficiency Virus Type 1 (HIV-1) Subtype on Women Receiving Single-Dose Nevirapine Prophylaxis to Prevent HIV-1 Vertical Transmission (HIV Network for Prevention Trials 012 Study)

    Susan H. Eshleman;Graziella Becker-Pergola;Martina Deseyve;Laura A. Guay

  • Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1.

    Tim R. Cressey;Gonzague Jourdain;Marc J. Lallemant;Suparat Kunkeaw

Frequent Co-Authors

Susan H. Eshleman
Susan H. Eshleman Johns Hopkins University School of Medicine
Mary Glenn Fowler
Mary Glenn Fowler Johns Hopkins University
Deborah Donnell
Deborah Donnell Fred Hutchinson Cancer Research Center
Susan A. Fiscus
Susan A. Fiscus University of North Carolina at Chapel Hill
Taha E. Taha
Taha E. Taha Johns Hopkins University
Saad B. Omer
Saad B. Omer The University of Texas Southwestern Medical Center
Donald R. Hoover
Donald R. Hoover Rutgers, The State University of New Jersey
Lynne M. Mofenson
Lynne M. Mofenson Elizabeth Glaser Pediatric AIDS Foundation
Henry H. Balfour
Henry H. Balfour University of Minnesota
Neil Parkin
Neil Parkin Data First COnsulting

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Aspiring professionals in Biology and Biochemistry have a variety of online degree opportunities to expand their career options. Many students pursue healthcare administration roles by enrolling in online mha programs cahme accredited, which ensure a rigorous and industry-respected curriculum. These programs are ideal for those interested in leadership within hospitals, clinics, and research institutions.

For nurses aiming to advance without traditional clinical components, there are flexible options like a dnp program without clinical hours. This pathway is especially suited to those focusing on leadership, policy, or educational roles in healthcare.

Graduate-level study also includes online doctoral programs such as the phd in healthcare management online, perfect for those who wish to enter academic, executive, or research positions in health services.

For students motivated by pharmaceutical sciences, pursuing an online pharmd offers the chance to become a licensed pharmacist or progress into regulatory, consulting, or academic fields. These online degrees open doors for biologists and biochemists to transition into specialized healthcare careers or leadership roles.

Best Scientists Citing J. Brooks Jackson

Trending Scientists

Recently Published Articles